Skip to main content

Table 1 NM treatment and toxicological end-points measured in the repeated exposure experiments over a period of 3 weeks

From: Assessment of nanomaterial-induced hepatotoxicity using a 3D human primary multi-cellular microtissue exposed repeatedly over 21 days - the suitability of the in vitro system as an in vivo surrogate

Experiment A

End-points investigated

Material dosing 1 at day 0

Medium replacement at day 1      24 h recovery period

AK assay, AST

Material dosing 2 at day 2

Medium replacement at day 3      24 h recovery period

Cytokine secretion, albumin

Material dosing 3 at day 4

Medium replacement at day 5      24 h recovery period

AK assay

Material dosing 4 at day 6

 

Medium replacement at day 7

Cytokine secretion, albumin

2 weeks recovery (medium change every other day) - collect supernatant day 21

AK assay, cytokine secretion

View full size image

Experiment B

End-points investigated

Material dosing 1 at day 0

Medium replacement at day 1      24 h recovery period

Material dosing 2 at day 2

Medium replacement at day 3      24 h recovery period

Material dosing 3 at day 4

Medium replacement at day 5      24 h recovery

Material dosing 4 at day 6

Medium replacement at day 7      24 h recovery

 

Material dosing 5 at day 8

Medium replacement at day 9      24 h recovery

Albumin, AST

Material dosing 6 at day 10

 

Medium replacement at day 11      24 h recovery

AK assay

Material dosing 7 at day 12

Treatment missed

Medium replacement at day 13      24 h recovery

 

Material dosing 8 at day 14

 

Medium replacement at day 15

Cytokine secretion, albumin

1 week recovery (medium change every other day) - collect supernatant day 21

AK assay, cytokine secretion

View full size image

Experiment C

End-points investigated

Material dosing 1 at day 0

Medium replacement at day 1      24 h recovery period

Material dosing 2 at day 2

Medium replacement at day 3      24 h recovery period

Material dosing 3 at day 4

Medium replacement at day 5      24 h recovery

Material dosing 4 at day 6

Medium replacement at day 7      24 h recovery

Material dosing 5 at day 8

Medium replacement at day 9      24 h recovery

Material dosing 6 at day 10

Medium replacement at day 11      24 h recovery

Material dosing 7 at day 12

Treatment missed

Medium replacement at day 13      24 h recovery

 

Material dosing 8 at day 14

Medium replacement at day 15      24 h recovery

 

Material dosing 9 at day 16

 

Medium replacement at day 17      24 h recovery

AST

Material dosing 10 at day 18

 

Medium replacement at day 19      24 h recovery

AK assay, albumin

Material dosing 11 at day 20

 

Collect supernatant day 21

AK assay, cytokine secretion, AST

View full size image